ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Radiation Protection & Shielding
The Radiation Protection and Shielding Division is developing and promoting radiation protection and shielding aspects of nuclear science and technology — including interaction of nuclear radiation with materials and biological systems, instruments and techniques for the measurement of nuclear radiation fields, and radiation shield design and evaluation.
Meeting Spotlight
2024 ANS Winter Conference and Expo
November 17–21, 2024
Orlando, FL|Renaissance Orlando at SeaWorld
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2024
Jan 2024
Latest Journal Issues
Nuclear Science and Engineering
October 2024
Nuclear Technology
Fusion Science and Technology
August 2024
Latest News
New laws offer nuclear industry incentives for existing power plant uprates
This year, the U.S. nuclear industry received a much-needed economic boost that could help preserve operating nuclear power plants and incentivize upgrades that extend their lifespan and power output.
Signed into law in 2022, the Inflation Reduction Act offers production tax credits (PTCs) for existing nuclear power plants and either PTCs or investment tax credits (ITCs) for new carbon-free generation. These credits could make power uprates—increasing the maximum power level at which a commercial plant may operate—a much more appealing option for utilities.
J. E. Woollard, T. E. Blue, J. F. Curran, M. C. Dobelbower, H. R. Busby, R. F. Barth
Nuclear Science and Engineering | Volume 110 | Number 1 | January 1992 | Pages 96-103
Technical Paper | doi.org/10.13182/NSE92-A23879
Articles are hosted by Taylor and Francis Online.
Boron neutron capture therapy (BNCT) is an experimental radiation therapy that is being developed for the treatment of malignant tumors. One requirement for successful BNCT is that a sufficient amount of 10B concentrates in the tumor while clearing from normal tissues and blood. Many pharmaceuticals are currently being developed to selectively deliver 10B to a tumor. To evaluate the effectiveness of various 10B delivery agents, the concentrations of boron in blood, tumor, and normal tissues must be known. Using the solid-state nuclear track detector CR-39, a tissue assay technique has been developed to spatially determine 10B concentrations in tissue samples. The technique has been used to quantify 10B concentrations in tumor and normal tissue on lines across rat brain tissue sections. This was done by combining 10B concentrations measured on lines across the CR-39 with color digital images of the tissue section. Coupling the methodology that was developed for tissue samples with an existing analytical technique for blood-10B concentration measurements allows for complete evaluation of 10B distributions in blood, tumor, and normal tissues and should be useful in evaluating various 10B delivery agents for use in BNCT.